What to Expect During Your First Weeks on Oral Semaglutide Most patients notice reduced appetite and increased fullness within the first week of starting oral semaglutide tablets, though the sensation strengthens over the first month as your body adjusts
Several potential risks arise from concurrent cannabis and Wegovy use, though robust clinical trial data specifically examining this combination are currently unavailable: Reduced treatment efficacy : The most significant concern is that cannabis-induced appetite stimulation may counteract Wegovy's appetite-suppressing effects, potentially compromising weight loss outcomes
Overall, berberines strength lies in metabolic regulation, especially blood glucose control, while Ozempic provides a more comprehensive therapeutic effect, targeting both glucose and appetite regulation pathways, often leading to more pronounced outcomes
You do not meet the medical necessity criteria
The approximately 5-9 percentage point difference in weight loss translates to meaningful clinical differences